Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 18 (4), 412-8

Dexmedetomidine in Anaesthesia

Affiliations

Dexmedetomidine in Anaesthesia

Andrea Paris et al. Curr Opin Anaesthesiol.

Abstract

Purpose of review: The development of dexmedetomidine, a potent and highly selective alpha2-adrenoceptor agonist, has created new interest in the use of alpha2-adrenoceptor agonists, and has led to its evaluation in various yet non-approved perioperative settings. The current review focuses on the usefulness of dexmedetomidine in anaesthesia practice.

Recent findings: Recently acquired knowledge and experience with dexmedetomidine in perioperative use will be presented and discussed in the context of known pharmacological properties.

Summary: Dexmedetomidine offers beneficial pharmacological properties, providing dose-dependent sedation, analgesia, sympatholysis and anxiolysis without relevant respiratory depression. The side-effects are predictable from the pharmacological profile of (2-adrenoceptor agonists. In particular, the unique sedative properties of dexmedetomidine resulted in several interesting applications in anaesthesia practice, promising benefits in the perioperative use of this compound. However, dexmedetomidine was approved for sedation in the intensive care unit in the USA in 1999, and administration in anaesthesia practice remains an 'off-label' use. Further studies are needed to establish the role of dexmedetomidine in the perioperative period.

Similar articles

  • [Dexmedetomidine]
    Y Sakaguchi et al. Masui 55 (7), 856-63. PMID 16856546. - Review
    Dexmedetomidine, a potent and highly selective alpha2-agonist, provides a unique "conscious sedation" (patients appear to be asleep, but are readily roused), analgesia, w …
  • Dexmedetomidine: A Review of Clinical Applications
    DS Carollo et al. Curr Opin Anaesthesiol 21 (4), 457-61. PMID 18660652. - Review
    Dexmedetomidine is a useful medication with many clinical applications. The medication has shown efficacy in decreasing the need for opioids, benzodiazepines, propofol, a …
  • Perioperative Use of alpha2-adrenoceptor Agonists and the Cardiac Patient
    R Aantaa et al. Eur J Anaesthesiol 23 (5), 361-72. PMID 16507202. - Review
    The centrally acting alpha2-adrenoceptor agonists clonidine and dexmedetomidine have been used with success to provide haemodynamic stability for patients undergoing surg …
  • Preliminary Experience With Dexmedetomidine for Monitored Anesthesia Care During ENT Surgical Procedures
    T Busick et al. Am J Ther 15 (6), 520-7. PMID 19127135. - Case Reports
    Dexmedetomidine is an alpha2-adrenergic agonist that produces anxiolysis, amnesia, sedation, potentiation of opioid analgesia, and sympatholysis. It is currently approved …
  • Dexmedetomidine: Current Role in Anesthesia and Intensive Care
    J Afonso et al. Rev Bras Anestesiol 62 (1), 118-33. PMID 22248773. - Review
    Dexmedetomidine offers a unique ability of providing both sedation and analgesia without respiratory depression. It is a new agent with a wide safety margin, excellent se …
See all similar articles

Cited by 41 PubMed Central articles

See all "Cited by" articles

LinkOut - more resources

Feedback